Cargando…
Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141265/ https://www.ncbi.nlm.nih.gov/pubmed/34059386 http://dx.doi.org/10.1016/j.ajem.2021.05.053 |
_version_ | 1783696330004103168 |
---|---|
author | Jolobe, Oscar M.P. |
author_facet | Jolobe, Oscar M.P. |
author_sort | Jolobe, Oscar M.P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8141265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81412652021-05-24 Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19 Jolobe, Oscar M.P. Am J Emerg Med Article Elsevier Inc. 2022-04 2021-05-23 /pmc/articles/PMC8141265/ /pubmed/34059386 http://dx.doi.org/10.1016/j.ajem.2021.05.053 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Jolobe, Oscar M.P. Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19 |
title | Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19 |
title_full | Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19 |
title_fullStr | Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19 |
title_full_unstemmed | Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19 |
title_short | Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19 |
title_sort | extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141265/ https://www.ncbi.nlm.nih.gov/pubmed/34059386 http://dx.doi.org/10.1016/j.ajem.2021.05.053 |
work_keys_str_mv | AT jolobeoscarmp extendingtheclinicalspectrumofthromboticthrombocytopenicsyndromeattributabletoadenovirusbasedvaccinesforcovid19 |